Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders

por Dussiau, Charles, Dupuy, Henry, Bidet, Audrey, Sauvezie, Mathieu, De-Grande, Anne-Charlotte, Boureau, Lisa, Riviere, Etienne, Forcade, Edouard, Bonnet, Fabrice, Dumas, Pierre-Yves, Duffau, Pierre, Pigneux, Arnaud, Viallard, Jean-François, Dimicoli-Salazar, Sophie, Lazaro, Estibaliz
Publicado 2023

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

por Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Largeaud, Laetitia, Bidet, Audrey, Delabesse, Eric, Leguay, Thibaut, Leroy, Harmony, Gadaud, Noémie, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, Sarry, Audrey, de Grande, Anne-Charlotte, Pigneux, Arnaud, Récher, Christian
Publicado 2020

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health ca...

por Galtier, Jean, Alric, Camille, Bérard, Emilie, Leguay, Thibaut, Tavitian, Suzanne, Bidet, Audrey, Delabesse, Eric, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, de Grande, Anne-Charlotte, Sarry, Audrey, Pigneux, Arnaud, Récher, Christian, Bertoli, Sarah, Dumas, Pierre-Yves
Publicado 2021

Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study

por Bertoli, Sarah, Dumas, Pierre-Yves, Bérard, Emilie, Largeaud, Laetitia, Bidet, Audrey, Delabesse, Eric, Tavitian, Suzanne, Gadaud, Noémie, Leguay, Thibaut, Leroy, Harmony, Rieu, Jean-Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, Sarry, Audrey, De Grande, Anne-Charlotte, Récher, Christian, Pigneux, Arnaud
Publicado 2020